The IL-17 family of cytokines in psoriasis: IL-17A and beyond

NC Brembilla, L Senra, WH Boehncke - Frontiers in immunology, 2018 - frontiersin.org
Psoriasis is a frequent chronic inflammatory skin disease, nowadays considered a major
global health problem. Several new drugs, targeting the IL-23/IL-17A pathway, have been …

[HTML][HTML] How do immune cells overcome the blood–brain barrier in multiple sclerosis?

C Larochelle, JI Alvarez, A Prat - FEBS letters, 2011 - Elsevier
The presence of the blood–brain barrier (BBB) restricts the movement of soluble mediators
and leukocytes from the periphery to the central nervous system (CNS). Leukocyte entry into …

DICAM promotes TH17 lymphocyte trafficking across the blood-brain barrier during autoimmune neuroinflammation

M Charabati, C Grasmuck, S Ghannam… - Science Translational …, 2022 - science.org
The migration of circulating leukocytes into the central nervous system (CNS) is a key driver
of multiple sclerosis (MS) pathogenesis. The monoclonal antibody natalizumab proved that …

Th17 cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic implications

GRD Passos, DK Sato, J Becker… - Mediators of …, 2016 - Wiley Online Library
Several animal and human studies have implicated CD4+ T helper 17 (Th17) cells and their
downstream pathways in the pathogenesis of central nervous system (CNS) autoimmunity in …

Shift work at young age is associated with increased risk for multiple sclerosis

AK Hedström, T Åkerstedt, J Hillert, T Olsson… - Annals of …, 2011 - Wiley Online Library
Objective: Environmental factors play a prominent role in multiple sclerosis (MS) etiology.
The aim of this study was to investigate the potential association between shift work and MS …

Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system

C Larochelle, R Cayrol, H Kebir, JI Alvarez… - Brain, 2012 - academic.oup.com
In multiple sclerosis, encephalitogenic CD4+ lymphocytes require adhesion molecules to
accumulate into central nervous system inflammatory lesions. Using proteomic techniques …

The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels

Z Babaloo, MR Aliparasti, F Babaiea, S Almasi… - Immunology letters, 2015 - Elsevier
Background and aims Multiple sclerosis (MS) is an inflammatory condition of the central
nervous system, with genetic and environmental factors having a role in its etiology. The …

Signs of the presence of Th17 cells in chronic periodontal disease

M Adibrad, P Deyhimi… - Journal of …, 2012 - Wiley Online Library
Adibrad M, Deyhimi P, Ganjalikhani Hakemi M, Behfarnia P, Shahabuei M, Rafiee L. Signs
of the presence of Th17 cells in chronic periodontal disease. J Periodont Res 2012; 47: 525 …

Bimekizumab: the first dual inhibitor of interleukin (IL)-17A and IL-17F for the treatment of psoriatic disease and ankylosing spondylitis

J Reis, R Vender, T Torres - BioDrugs, 2019 - Springer
Psoriasis is a chronic inflammatory skin disease with significant psychological and physical
impact. Over the last few decades, several highly effective target therapies have been …

Increased IL-17A but decreased IL-27 serum levels in patients with multiple sclerosis

Z Babaloo, R Khajir Yeganeh, M Farhoodi… - Iranian Journal of …, 2013 - iji.sums.ac.ir
Background: Effector CD4+ T cell subsets play an important role in Multiple Sclerosis (MS).
Interleukin-27 (IL-27) suppresses Th (Th1, Th2 and Th17) cells and dampens autoimmunity …